Logotipo del repositorio
  • English
  • Español
  • Iniciar sesión
    ¿Nuevo Usuario? Pulse aquí para registrarse¿Has olvidado tu contraseña?
Logotipo del repositorio
  • ¿Qué es SIC?
  • Estadísticas
  • Guía de Usuario
  • English
  • Español
  • Iniciar sesión
    ¿Nuevo Usuario? Pulse aquí para registrarse¿Has olvidado tu contraseña?
  • Inicio
  • Personal de Investigación
  • Unidad Académica
  • Publicaciones
  • Colecciones
    • Datos de investigación
    • Divulgación Científica
    • Personal de investigación
    • Protecciones
    • Proyectos externos
    • Proyectos internos
    • Publicaciones
    • Tesis
  1. Inicio
  2. Universidad de Santiago de Chile
  3. Publicaciones
  4. Development of Ferrocenyl and Ruthenocenyl Zileuton Analogs with Enhanced Bioactivity toward Human 5-Lipoxygenase: Innovation in Drugs for Inflammatory Diseases
 
  • Details
Options

Development of Ferrocenyl and Ruthenocenyl Zileuton Analogs with Enhanced Bioactivity toward Human 5-Lipoxygenase: Innovation in Drugs for Inflammatory Diseases

ISSN
0020-1669
Date Issued
2025
Author(s)
Mascayano-Collado, C 
Departamento de Ciencias del Ambiente 
Navarrete-Tudela, E 
Departamento de Ciencias del Ambiente 
Caceres, Tomas
Cariou, Kevin
Flores, Erick
Gasser, Gilles
Godoy, Fernando
Mesdom, Pierre
Morales, Pilar
Vega, Andres
DOI
http://doi.org/10.1021/acs.inorgchem.4c05103
Abstract
Zileuton is the only FDA-approved 5-lipoxygenase (5-LOX) inhibitor for asthma treatment, but it produces hepatotoxicity associated with the benzothiophene fragment. Using the concept of organometallic derivatization pioneered by Jaouen and Brocard, we synthesized five new organometallic Zileuton derivatives, maintaining the urea fragment and incorporating ferrocenyl and ruthenocenyl moiety (3a-e). Their biological activity was evaluated against 5-LOX, 15-LOX, COX-1, and COX-2 enzymes. The ferrocenyl and ruthenocenyl N-hydroxyurea complexes coined Ferroleuton (3a) and Ruthenoleuton (3e) showed the highest selective inhibitory activity against 5-LOX, with IC50 values of 0.21 +/- 0.12 and 3.49 +/- 1.11 mu M, respectively. Notably, 3a exhibited superior activity compared to Zileuton (IC50 0.67 +/- 0.09 mu M), demonstrating the key role of N-hydroxyurea and ferrocenyl fragments in the inhibitory process. Worthy of note, both compounds displayed low cytotoxicity in lung fibroblast healthy cells line (MRC-5) (CC50 of 116.40 and >200 mu M, respectively). Enzyme kinetic studies indicated competitive and mixed types of inhibition for 3a and 3e, respectively. Additionally, they demonstrated superior antioxidant capacity compared to Zileuton (DPPH, ABTS, and FRAP assays). Electrochemical and molecular dynamics (MD) studies suggest a chelating-redox deactivation mechanism for 5-LOX. These findings position Ferroleuton (3a) and Ruthenoleuton (3e) as promising candidates for inflammatory disease treatment.
...
Universidad de Santiago de Chile Avenida Libertador Bernardo O'Higgins nº 3363. Estación Central. Santiago Chile. admin.dspace@usach.cl © 2023 The DSpace CRIS Project - Modificado por VRIIC USACH.
...